Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15380820rdf:typepubmed:Citationlld:pubmed
pubmed-article:15380820lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:15380820lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15380820lifeskim:mentionsumls-concept:C2340138lld:lifeskim
pubmed-article:15380820lifeskim:mentionsumls-concept:C0012472lld:lifeskim
pubmed-article:15380820lifeskim:mentionsumls-concept:C0033567lld:lifeskim
pubmed-article:15380820lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15380820lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:15380820pubmed:issue5lld:pubmed
pubmed-article:15380820pubmed:dateCreated2004-9-21lld:pubmed
pubmed-article:15380820pubmed:abstractTextHepatic stellate cells (HSC) are central to liver fibrosis. The eicosanoid pathway and cyclooxygenase-2 (COX-2) may be an important signaling mechanism in HSC. We investigated the role of COX-2, prostaglandin E(2) (PGE(2)) and prostaglandin I(2) (PGI(2)) in proliferation of LI90, an immortalized cell line of HSC. Our results showed that COX-2 was upregulated by platelet-derived growth factor (PDGF), a mitogen in HSC. COX-2 was responsible for the production of PGE(2) and PGI(2) in PDGF-stimulated LI90 cells. Furthermore, we demonstrated that COX-2 and PGE(2) mediated the proliferative response of LI90 to PDGF while synthetic analogue of PGI(2) exhibited anti-proliferative effect. Our findings suggest complex interactions of prostaglandins in liver fibrogenesis. In vivo studies using animal models are needed to elucidate the effect of COX-2 inhibition by non-steroidal anti-inflammatory drugs or COX-2 inhibitor in hepatic fibrosis.lld:pubmed
pubmed-article:15380820pubmed:languageenglld:pubmed
pubmed-article:15380820pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15380820pubmed:citationSubsetIMlld:pubmed
pubmed-article:15380820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15380820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15380820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15380820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15380820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15380820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15380820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15380820pubmed:statusMEDLINElld:pubmed
pubmed-article:15380820pubmed:monthNovlld:pubmed
pubmed-article:15380820pubmed:issn0952-3278lld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:SataMichioMlld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:ChanHenry...lld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:SungJoseph...lld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:HuiAlex YuiAYlld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:UenoTakatoTlld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:ChanFrancis...lld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:SakataRyuichi...lld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:ChengAlfred...lld:pubmed
pubmed-article:15380820pubmed:authorpubmed-author:GoMinnie...lld:pubmed
pubmed-article:15380820pubmed:issnTypePrintlld:pubmed
pubmed-article:15380820pubmed:volume71lld:pubmed
pubmed-article:15380820pubmed:ownerNLMlld:pubmed
pubmed-article:15380820pubmed:authorsCompleteYlld:pubmed
pubmed-article:15380820pubmed:pagination329-33lld:pubmed
pubmed-article:15380820pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:meshHeadingpubmed-meshheading:15380820...lld:pubmed
pubmed-article:15380820pubmed:year2004lld:pubmed
pubmed-article:15380820pubmed:articleTitleEffect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line.lld:pubmed
pubmed-article:15380820pubmed:affiliationDepartment of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong. alexyhui@yahoo.comlld:pubmed
pubmed-article:15380820pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15380820pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed